0 Comentários
0 Compartilhamentos
3K Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Global Drug Discovery Outsourcing Market Size, Share, Key Drivers, Growth Opportunities and Global Trends 2032The global Drug Discovery Outsourcing Market is expected to reach USD 7.20 Biliion by the end of 2032, with a valuation of USD 3.79 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 7.4%. The study examines the factors driving and limiting the global Drug Discovery Outsourcing...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Unlocking Large Molecule Drug Discovery Outsourcing Market Potential: Future Trends, Growth Drivers, and InsightsIn its latest publication, Polaris Market Research presents an in-depth analysis of the Large Molecule Drug Discovery Outsourcing Market. It captures the segmentation-driven shifts defining growth opportunities, competitive dynamics, and solution development within the industry. This comprehensive report combines historical data, real-time analytics, and forward-looking projections to...0 Comentários 0 Compartilhamentos 731 Visualizações 0 Anterior
-
Mergers, Acquisitions, and Capacity Expansion: How CROs Are Scaling for Global DemandThe global small molecule drug discovery outsourcing market, valued at USD 4.48 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 9.68% from 2025 to 2034, driven by rising R&D costs, talent shortages, and the pharmaceutical industry’s strategic pivot toward external innovation. This growth is not uniform across geographies, as regional disparities in...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Mergers, Acquisitions, and Expansion: How Global CROs Are Strengthening U.S. OperationsThe U.S. small molecule drug discovery outsourcing market, valued at USD 1.49 billion in 2024, is anticipated to expand at a CAGR of 9.48% from 2025 to 2034, with growth increasingly driven by segment-wise performance across service types, therapeutic areas, and technological platforms. Unlike biologics development, which relies on biological systems, small molecule discovery remains rooted in...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
Patrocinado